BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26311223)

  • 21. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
    Chen D; Bhat-Nakshatri P; Goswami C; Badve S; Nakshatri H
    Cancer Res; 2013 Sep; 73(18):5821-33. PubMed ID: 23832666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations.
    Liu H; Cadaneanu RM; Lai K; Zhang B; Huo L; An DS; Li X; Lewis MS; Garraway IP
    Prostate; 2015 May; 75(7):764-76. PubMed ID: 25663004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.
    Lim E; Vaillant F; Wu D; Forrest NC; Pal B; Hart AH; Asselin-Labat ML; Gyorki DE; Ward T; Partanen A; Feleppa F; Huschtscha LI; Thorne HJ; ; Fox SB; Yan M; French JD; Brown MA; Smyth GK; Visvader JE; Lindeman GJ
    Nat Med; 2009 Aug; 15(8):907-13. PubMed ID: 19648928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in
    Hu L; Su L; Cheng H; Mo C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Zhang J; Xie Y
    Cancer Res; 2021 May; 81(10):2600-2611. PubMed ID: 33727227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
    Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
    PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of minor subpopulations of colorectal adenocarcinoma cells expressing cancer stem cell markers.
    Gisina AM; Lupatov AY; Karalkin PA; Mainovskaya OA; Petrov LO; Sidorov DV; Yarygin VN; Yarygin KN
    Bull Exp Biol Med; 2011 Jun; 151(2):234-8. PubMed ID: 22238758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
    Tveito S; Andersen K; Kåresen R; Fodstad Ø
    Breast Cancer Res; 2011 Aug; 13(4):R75. PubMed ID: 21816090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
    Mitra M; Kandalam M; Harilal A; Verma RS; Krishnan UM; Swaminathan S; Krishnakumar S
    Mol Vis; 2012; 18():290-308. PubMed ID: 22328825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.
    Wright MH; Robles AI; Herschkowitz JI; Hollingshead MG; Anver MR; Perou CM; Varticovski L
    Mol Cancer; 2008 Apr; 7():29. PubMed ID: 18394172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
    PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer.
    Vieira AF; Ricardo S; Ablett MP; Dionísio MR; Mendes N; Albergaria A; Farnie G; Gerhard R; Cameselle-Teijeiro JF; Seruca R; Schmitt F; Clarke RB; Paredes J
    Stem Cells; 2012 May; 30(5):854-64. PubMed ID: 22389315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EpCAM expression in the prostate cancer makes the difference in the response to growth factors.
    Yoshida GJ; Saya H
    Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.
    Wei X; Dombkowski D; Meirelles K; Pieretti-Vanmarcke R; Szotek PP; Chang HL; Preffer FI; Mueller PR; Teixeira J; MacLaughlin DT; Donahoe PK
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18874-9. PubMed ID: 20952655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
    Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
    Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EpCAM and its potential role in tumor-initiating cells.
    Imrich S; Hachmeister M; Gires O
    Cell Adh Migr; 2012; 6(1):30-8. PubMed ID: 22647938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.